Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(17%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_1
4
67%
Ph phase_2
1
17%
Ph not_applicable
1
17%

Phase Distribution

4

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
4(66.7%)
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(2)

Detailed Status

unknown2
Completed2
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 14 (66.7%)
Phase 21 (16.7%)
N/A1 (16.7%)

Trials by Status

active_not_recruiting117%
unknown233%
completed233%
withdrawn117%

Recent Activity

1 active trials
Showing 5 of 6
completedphase_2

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

NCT03603808
active_not_recruitingnot_applicable

Comparison of Different Electroporation Systems in the Ablation Treatment of Atrial Fibrillation

NCT06646887
completedphase_1

Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma

NCT02514421
withdrawnphase_1

Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma

NCT02592395
unknownphase_1

Calcium Electroporation for Head and Neck Cancer

NCT03051269
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT03603808Phase 2

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Completed
NCT06646887Not Applicable

Comparison of Different Electroporation Systems in the Ablation Treatment of Atrial Fibrillation

Active Not Recruiting
NCT02514421Phase 1

Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma

Completed
NCT02592395Phase 1

Study of FOLFIRINOX Electrochemotherapy in the Treatment of Pancreatic Adenocarcinoma

Withdrawn
NCT03051269Phase 1

Calcium Electroporation for Head and Neck Cancer

Unknown
NCT02822066Phase 1

Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and Pancreas

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
6